Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

One of the potential clinical uses of the new cerebral blood flow agent 99mTc-hexamethylpropyleneamineoxime (HM-PAO) is the investigation of dementia, in particular to differentiate between dementia of the Alzheimer type (DAT) and multiinfarct dementia (MID). In this study 27 patients, 17 with DAT a...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Gemmell, H, Sharp, P, Besson, J, Crawford, JR, Ebmeier, K, Davidson, J, Smith, F
פורמט: Journal article
שפה:English
יצא לאור: 1987

פריטים דומים